4.5 Article

Impact of donor-derived CD34+infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation

Juan Carlos Hernandez-Boluda et al.

Summary: This study aimed to evaluate survival determinants in myelofibrosis patients undergoing allo-HCT and describe factors predicting post-HCT complications. Factors associated with increased mortality included age, Karnofsky Performance Status, graft failure, aGVHD, and disease progression/relapse. Risk of aGVHD and relapse incidence varied with donor type and conditioning regimen, with GVHD having a complex impact on relapse and survival.

LEUKEMIA (2021)

Article Hematology

Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT)

Nicola Polverelli et al.

Summary: The role of spleen size and splenectomy in predicting post-allogeneic hematopoietic stem cell transplant outcomes in myelofibrosis patients remains debated. However, splenectomy may improve survival and reduce non-transplant related mortality in patients with progressive disease and massive splenomegaly.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Article Medicine, Research & Experimental

European wide survey on allogeneic haematopoietic cell transplantation practice for myelofibrosis on behalf of the EBMT chronic malignancies working party

Donal P. McLornan et al.

Summary: The survey revealed marked variations in practices across European allo-HCT centers for myelofibrosis, prompting future CMWP efforts to focus on defining guidelines for relapse and suggesting optimal monitoring practices for the transplant community.

CURRENT RESEARCH IN TRANSLATIONAL MEDICINE (2021)

Review Oncology

Myelofibrosis in 2019: moving beyond JAK2 inhibition

Michael Schieber et al.

BLOOD CANCER JOURNAL (2019)

Article Hematology

Effect of Total Nucleated and CD34+ Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation

Mats Remberger et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)

Article Medicine, General & Internal

Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors

Claudio Anasetti et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Hematology

Defining the Intensity of Conditioning Regimens: Working Definitions

Andrea Bacigalupo et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)